RBC Capital Downgrades ResMed (RMD) to Sector Perform

August 12, 2022 5:59 AM EDT
Get Alerts RMD Hot Sheet
Price: $229.92 +0.25%

Rating Summary:
    11 Buy, 11 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 5 | New: 0
Join SI Premium – FREE

RBC Capital analyst Craig Wong-Pan downgraded ResMed (NYSE: RMD) from Outperform to Sector Perform with a price target of $252.00 (from $246.00).

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $240.85 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades